BioDelivery Sciences International is a pharmaceutical company focused on delivering therapies for individuals living with serious and debilitating chronic conditions. Co. has built a portfolio of products that includes utilizing its proprietary BioErodible MucoAdhesive drug-delivery technology to develop and commercialize new applications of therapies. Co.'s marketed products include: BELBUCA for the management of pain severe enough to require long-term opioid treatment and for which alternative treatment options are inadequate; and Symproic for the management of opioid-induced constipation in adult patients with chronic non-cancer pain. The BDSI stock yearly return is shown above.
The yearly return on the BDSI stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2013 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the BDSI annual return calculation with any dividends reinvested as applicable (on ex-dates).
|